This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Clinical Diagnosis/diagnosis,
Betacoronavirus/drug effects,
Coronavirus Infections/diagnosis,
Pneumonia, Viral/diagnosis,
Hypoxia/diagnosis,
Patient Acuity,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Dexamethasone/therapeutic use,
Breast Feeding,
Antiviral Agents/therapeutic use,
Hydroxychloroquine/therapeutic use,
Colchicine/therapeutic use,
Plasma/immunology,
Darunavir/therapeutic use,
Interferons/therapeutic use,
Evidence-Based Practice/methods
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications....
Definir los criterios de diagnóstico de la enfermedad y las pruebas que se deben realizar al paciente para su evaluación. Brindar indicaciones de manejo de PTI aguda, crónica y persistente. Proponer opciones de tratamiento de acuerdo a la evidencia disponible. Dar indicación de manejo en PTI con r...
Thrombocytopenia/diagnosis,
Thrombocytopenia/therapy,
Platelet Count,
Anemia, Hemolytic,
Dexamethasone/therapeutic use,
Receptors, Thrombopoietin/agonists,
Rituximab/therapeutic use,
Splenectomy,
Thrombocytopenia/surgery
Ofrecer recomendaciones basadas en la evidencia para la prevención, detección, tratamiento y seguimiento de las queratosis actínicas, con el fin de apoyar al personal de salud en los diferentes niveles de atención, buscando garantizar una atención integral, homogénea, con calidad, equidad y eficien...
Leukemia, Lymphoid/diagnosis,
Leukemia, Lymphoid/therapy,
Leukemia, Myeloid/diagnosis,
Leukemia, Myeloid/therapy,
Cytogenetic Analysis/methods,
Vincristine/therapeutic use,
Doxorubicin/therapeutic use,
Dexamethasone/therapeutic use,
Imatinib Mesylate/therapeutic use,
Dasatinib/therapeutic use,
Antibodies, Monoclonal/therapeutic use,
Drug Therapy, Combination,
Transplantation, Homologous
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma
and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people
with myeloma by promoting the most effective tests and treatments for myeloma and its
complications....
